This paper is in the following e-collection/theme issue:

Reviews on Public Health Technology and Innovation (36) HIV/AIDS/STI Prevention and Care (663) Participatory Epidemiology and Surveillance (92) Surveillance Systems (359)

Published on in Vol 8 , No 3 (2022) :March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/34410, first published .
Use of HIV Recency Assays for HIV Incidence Estimation and Other Surveillance Use Cases: Systematic Review

Use of HIV Recency Assays for HIV Incidence Estimation and Other Surveillance Use Cases: Systematic Review

Use of HIV Recency Assays for HIV Incidence Estimation and Other Surveillance Use Cases: Systematic Review

Authors of this article:

Shelley N Facente 1, 2, 3 Author Orcid Image ;   Eduard Grebe 1, 3, 4 Author Orcid Image ;   Andrew D Maher 4, 5 Author Orcid Image ;   Douglas Fox 2 Author Orcid Image ;   Susan Scheer 2 Author Orcid Image ;   Mary Mahy 6 Author Orcid Image ;   Shona Dalal 7 Author Orcid Image ;   David Lowrance 7 Author Orcid Image ;   Kimberly Marsh 6 Author Orcid Image
Article Authors Cited by (5) Tweetations (6) Metrics

Journals

  1. Kin-On Lau J, Murdock N, Murray J, Justman J, Parkin N, Miller V. A systematic review of limiting antigen avidity enzyme immunoassay for detection of recent HIV-1 infection to expand supported applications. Journal of Virus Eradication 2022;8(3):100085 View
  2. Nikolopoulos G, Tsantes A. Recent HIV Infection: Diagnosis and Public Health Implications. Diagnostics 2022;12(11):2657 View
  3. Sokhela S, Lalla-Edward S, Siedner M, Majam M, Venter W. Roadmap for Achieving Universal Antiretroviral Treatment. Annual Review of Pharmacology and Toxicology 2023;63(1):99 View
  4. Mohloanyane T, Olivier D, Labhardt N, Amstutz A, Lessells R. Recent HIV infections among newly diagnosed individuals living with HIV in rural Lesotho: Secondary data from the VIBRA cluster-randomized trial. PLOS ONE 2022;17(11):e0277812 View
  5. Parkin N, Gao F, Grebe E, Cutrell A, Das M, Donnell D, Duerr A, Glidden D, Hughes J, Murray J, Robertson M, Zinserling J, Lau J, Miller V, Pottinger Y, Lehnert R, Mastro T, Grinsztejn B, Tchelidze T, Baeten J, Carter C, Cox S, Ebrahimi R, Kintu A, Rooney J, Shao Y, Justman J, Rosenberg Z, Laeyendecker O, Eshelman S, Cowan F, Rice B, Ma J, Russell E, Squires K, Mink R, Welte A, Struble K, Zeng W, Dunn D, Dailey P, McCoy S, Rutherford G, Welty S, Parekh B, Smith D, Ghazaryan L, Vannappagari V, Busch M, Hodder S. Facilitating Next‐Generation Pre‐Exposure Prophylaxis Clinical Trials UsingHIVRecent Infection Assays: A Consensus Statement from the ForumHIVPrevention Trial Design Project. Clinical Pharmacology & Therapeutics 2023 View